相关实验视频
Updated: Jul 19, 2025

11:45
Quantifying Agonist Activity at G Protein-coupled Receptors
Published on: December 26, 2011
19.3K
α1A-上腺素受体的激素特异性的结构基础
Minfei Su1, Jinan Wang2, Guoqing Xiang3,4
1Department of Physiology and Biophysics, Weill Cornell Medical College of Cornell University, New York, NY, 10065, USA.
Nature communications
|August 10, 2023
概括
新的冷EM结构揭示了激动剂如何区分α-1上腺素受体亚型. 这促进了对受体功能的理解,并使特定亚型药物的合理设计成为可能.
科学领域:
- 结构生物学 结构生物学
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
背景情况:
- 阿尔法-1上腺素受体 (α1-ARs) 对于心血管和神经系统的功能至关重要.
- 亚型特异性激动剂的有限可用性阻碍了对α1-AR生理学和药物开发的研究.
研究的目的:
- 阐明激动剂对α1-AR亚型歧视的分子机制.
- 为了促进新型,亚型特定α1-AR激动剂的开发.
主要方法:
- 低温电子显微镜 (cryo-EM) 用于确定α1A-AR与G蛋白和激动剂结合的结构.
- 分子动力学模拟来分析激动剂-受体相互作用.
- 蛋白质工程创造突变受体与改变的激素反应.
主要成果:
- 获得了α1A-AR与上腺素和特定激动剂A61603.03的冷-EM结构.
- 揭示了A61603如何区分α1A-AR和α1B-AR的分子细节.
- 设计的α1A-AR突变体对A61603无反应,以及由A61603.03激活的α1B-AR突变体.
结论:
- 已经取得了对α1-AR激动剂特异性的结构性见解.
- 这些发现为选择性亚型α1-AR调节器的合理设计铺平了道路.
- 这项研究提升了开发针对性治疗方法的潜力,用于涉及α1-AR信号的疾病.
更多相关视频
相关概念视频
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.1K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.1K
Adrenergic Receptors: ɑ Subtype
1.6K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.6K
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
922
Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
922
Drug-Receptor Interaction: Agonist
2.5K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.5K
Adrenergic Receptors: β Subtype
1.7K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.7K
Adrenergic Receptors (Adrenoceptors): Classification
2.7K
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
2.7K

